Výsledky vyhledávání - "Sufyan Sayyed"

Supplementary Fig. S4 from Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib

Autor: Rickmer Braren, Irene Esposito, Andreas Steingötter, Ernst Rummeny, Markus Schwaiger, Oliver Ebert, Jennifer Altomonte, Juliane Dworniczak, Anna Melissa Schlitter, Marcus Settles, Horst Zitzelsberger, Kristian Unger, Julia Heß, Axel Walch, Annette Feuchtinger, Irina Heid, Sufyan Sayyed, Katja Steiger, Claudia Groß

Supplementary Fig. S4. Tumor vascularization and necrosis in human HCC.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35853db2c1b6e4c8f003ec3cdc57eb99
https://doi.org/10.1158/1078-0432.22458158.v1

Zobrazit plný text záznamu

Supplementary tables S1-3 and figure legends from Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib

Supplementary tables S1-3 and figure legends. Supplementary Table S1. Antibodies and antibody dilution used for immunohistochemical analyses. Supplementary Table S2. Characterization of human HCC Supplementary Table S3. Number of tumors per analyzed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427fc122f01258d73d20c1b1fac15ea7
https://doi.org/10.1158/1078-0432.22458155.v1

Zobrazit plný text záznamu

Supplementary Fig. S3 from Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib

Supplementary Fig. S3. aCGH analyses.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::685dd33c13bdb627c932776bdbacfcbc
https://doi.org/10.1158/1078-0432.22458161.v1

Zobrazit plný text záznamu

Supplementary Fig. S2 from Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib

Supplementary Fig. S2. Macrophage and T-lymphocyte infiltration in DEN and McA animals.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8535ec27e7ae8b6b32cdc60056dd03f1
https://doi.org/10.1158/1078-0432.22458164.v1

Zobrazit plný text záznamu

Supplementary Fig. S1 from Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib

Supplementary Fig. S1. Schematic of study design.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d40111fb209200072b733fc45d105c5
https://doi.org/10.1158/1078-0432.22458167

Zobrazit plný text záznamu

Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib

Autor: Markus Schwaiger, Kristian Unger, Anna Melissa Schlitter, Irina Heid, Juliane Dworniczak, Axel Walch, M Settles, Horst Zitzelsberger, Sufyan Sayyed, A Steingötter, Ernst J. Rummeny, Annette Feuchtinger, I Esposito, Julia Heß, Rickmer Braren, Katja Steiger, Claudia Groß, Oliver Ebert, Jennifer Altomonte

Publikováno v: Clin. Cancer Res. 21, 4440-4450 (2015)

Purpose: Preclinical model systems should faithfully reflect the complexity of the human pathology. In hepatocellular carcinoma (HCC), the tumor vasculature is of particular interest in diagnosis and therapy. By comparing two commonly applied preclin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799040c178b01569826cbc4c4f98913d
https://pubmed.ncbi.nlm.nih.gov/25995341

Zobrazit plný text záznamu

Abstract C8: Endogenous mouse models of pancreatic adenocarcinoma as a preclinical trial platform characterized by multiparametric magnetic resonance imaging

Autor: Bernhard Haller, Rickmer Braren, Sufyan Sayyed, Peter B. Noël, Irina Heid, Jens T. Siveke, Y Kosanke, M Gretzinger, Ernst J. Rummeny, Marija Trajkovic-Arsic, Andreas Steingoetter, Roland M. Schmid

Publikováno v: Cancer Research. 71:C8-C8

Development of strategies for early tumor detection and evaluation of new therapies in preclinical models is one of the main goals of current cancer research. Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with no effective treatment pla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ee1217c09b9d9728a0ab66bd06b93f7
https://doi.org/10.1158/1538-7445.fbcr11-c8

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání